Brief: Quince Therapeutics - Offers 15,470,099 Shares Of Common Stock For Resale - SEC Filing
31/07/2026 22:16
BRIEF-Quince Therapeutics - Offers 15,470,099 Shares Of Common Stock For Resale - SEC Filing July 31 (Reuters) - Quince Therapeutics Inc QNCX.O:
QUINCE THERAPEUTICS - OFFERS 15,470,099 SHARES OF COMMON STOCK FOR RESALE - SEC FILING
Source text: [ID:n0001193125-26-328769]
Further company coverage: QNCX.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges